Kyle Jenne
Fortune : 2 M $ au 31/05/2026
Fortune : 2 M $ au 31/05/2026
Kyle Jenne currently works at Ionis Pharmaceuticals, Inc., as Chief Global Product Strategy Officer & EVP from 2024.
Mr. Jenne also formerly worked at Elsie Biotechnologies Inc., as Chief Executive Officer & Director, Ionis Pharmaceuticals, Inc., as Chief Commercial Officer & Executive VP, and Akcea Therapeutics, Inc., as Senior Vice President-US Commercial from 2017 to 2019.
Mr. Jenne received his undergraduate degree from Arizona State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/04/2026 | 23 713 ( 0,01% ) | 2 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 29/02/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Elsie Biotechnologies Inc.
Elsie Biotechnologies Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops oligonucleotide therapeutics | Directeur Général | - |
| AKCEA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Arizona State University
Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akcea Therapeutics, Inc.
Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cardiometabolic lipid disorders | Health Technology |
Elsie Biotechnologies Inc.
Elsie Biotechnologies Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops oligonucleotide therapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national